The meeting, organized by the IRCCS Ca’ Granda Foundation Polyclinic Hospital and the Angelo Bianchi Bonomi Hemophilia and Thrombosis Center of Milan, Italy, is meant to take the best of both conferences and feature only the most novel advances of basic science and clinical research in hemophilia, rare inherited coagulation disorders, von Willebrand factor and von Willebrand disease, gene therapy, the thrombotic microangiopathies (TTP, HUS and aHUS) and, of course, factor VIII inhibitors. Clinical and translational science will be discussed from different angles during a full 3-day programme. The most distinguished experts in the field will present their very latest data and offer their wisdom and insight into the current science developments. Junior and less junior attendees will be able to submit their abstracts and have the chance to present them as oral communications or e-posters.
The conference is popular among the most distinguished international experts who aim to bring their novel therapeutical approaches.